Chargement en cours...
Immunology beats cancer: a blueprint for successful translation
Immunology offers an unprecedented opportunity for the science-driven development of therapeutics. The successes of antibodies to the immunomodulatory receptor CTLA-4 and blockade of the immunoinhibitory receptor PD-1 in cancer immunotherapy, from gene discovery to patient benefit, have created a pa...
Enregistré dans:
Publié dans: | Nat Immunol |
---|---|
Auteur principal: | |
Format: | Artigo |
Langue: | Inglês |
Publié: |
2012
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4659410/ https://ncbi.nlm.nih.gov/pubmed/23160205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ni.2392 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|